These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33278069)

  • 41. Hyaluronan and peritoneal ultrafiltration: a test of the "filter-cake" hypothesis.
    Rosengren BI; Carlsson O; Rippe B
    Am J Kidney Dis; 2001 Jun; 37(6):1277-85. PubMed ID: 11382699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphate clearance in peritoneal dialysis.
    Debowska M; Gomez R; Pinto J; Waniewski J; Lindholm B
    Sci Rep; 2020 Oct; 10(1):17504. PubMed ID: 33060672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of peritoneal equilibration test during treatment with polyglucose dialysis solution.
    Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M
    Perit Dial Int; 2002; 22(3):357-64. PubMed ID: 12227394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study.
    Vonesh EF; Burkart J; McMurray SD; Williams PF
    Perit Dial Int; 1996; 16(5):471-81. PubMed ID: 8914177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peritoneal kinetics in children undergoing continuous ambulatory/cycling peritoneal dialysis.
    von Lilien T; Salusky IB; Little RJ; Alliapolous JC; Leichter HE; Hall TL; Fine RN
    Am J Kidney Dis; 1987 Dec; 10(6):431-8. PubMed ID: 3120579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A quantitative description of solute and fluid transport during peritoneal dialysis.
    Heimbürger O; Waniewski J; Werynski A; Lindholm B
    Kidney Int; 1992 May; 41(5):1320-32. PubMed ID: 1614047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusive and convective solute transport in peritoneal dialysis with glucose as an osmotic agent.
    Waniewski J; Heimbürger O; Werynski A; Park MS; Lindholm B
    Artif Organs; 1995 Apr; 19(4):295-306. PubMed ID: 7598648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.
    Tzamaloukas AH; Malhotra D; Murata GH
    ASAIO J; 1998; 44(6):828-34. PubMed ID: 9831093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
    van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT
    Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urea and uremic solutes: how does peritoneal dialysis work?
    Bammens B
    Semin Nephrol; 2011 Mar; 31(2):127-37. PubMed ID: 21439427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
    Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
    Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
    Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
    Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.
    Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
    Kidney Int; 2003 Dec; 64(6):2238-43. PubMed ID: 14633148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of peritoneal permeability and residual renal function on PD prescription.
    Harty J; Gokal R
    Perit Dial Int; 1996; 16 Suppl 1():S147-52. PubMed ID: 8728182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.
    Evenepoel P; Bammens B; Verbeke K; Vanrenterghem Y
    Kidney Int; 2006 Aug; 70(4):794-9. PubMed ID: 16820785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous flow peritoneal dialysis: current state-of-the-art and obstacles to further development.
    Ronco C; Amerling R
    Contrib Nephrol; 2006; 150():310-320. PubMed ID: 16721024
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Creatinine clearance in continuous peritoneal dialysis: dialysis dose required for a minimal acceptable level.
    Tzamaloukas AH; Murata GH; Malhotra D; Fox L; Goldman RS; Avasthi PS
    Perit Dial Int; 1996; 16(1):41-7. PubMed ID: 8616171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function.
    Selgas R; Bajo MA; Cirugeda A; del Peso G; Valdés J; Castro MJ; Sánchez S; Fernández-Reyes MJ; Hevia C; Gil F; Aguilera A; Ortiz J; Alegre L; Alvarez V; Sánchez-Tomero JA
    Perit Dial Int; 2005; 25(1):68-76. PubMed ID: 15770928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A regenerable potassium and phosphate sorbent system to enhance dialysis efficacy and device portability: a study in awake goats.
    Wester M; Gerritsen KG; Simonis F; Boer WH; Hazenbrink DH; Vaessen KR; Verhaar MC; Joles JA
    Nephrol Dial Transplant; 2017 Jun; 32(6):951-959. PubMed ID: 27220758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peritoneal membrane transport function in children receiving long-term dialysis.
    Warady BA; Alexander SR; Hossli S; Vonesh E; Geary D; Watkins S; Salusky IB; Kohaut EC
    J Am Soc Nephrol; 1996 Nov; 7(11):2385-91. PubMed ID: 8959629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.